|
|
|
|
|
|
Sponsored by: |
University of California, Los Angeles |
Information provided by: | University of California, Los Angeles |
ClinicalTrials.gov Identifier: | NCT00675675 |
The study aims to clarify the functional anatomy of key brain circuits associated with cognitive control in children and adolescents with chronic tic disorders (CTD) and to compare and contrast hypothesized mechanisms related to increased tic control associated with Habit Reversal Training, a behavioral treatment that been previously shown to be effective in treating CTD. We also seek to better understand the relationship between fMRI and quantitative EEG in relevant brain circuits with the hope of establishing EEG as a valid and cost-effective marker of treatment responsiveness. A total of 25 subjects will be randomized to 10 weeks of Habit Reversal Training (HRT), a behavioral treatment, and 25 to 10 weeks of minimal-contact waitlist. Treatment responders will be re-assessed at three months. Waitlist nonresponders will be provided with 10 weeks of HRT. Study assessments, including a neurocognitive battery and quantitative EEG will be administered at baseline, Wk 5, Wk 10, and 3-month follow-up. Neuroimaging (fMRI) will be conducted at baseline and Wk 10.
Condition | Intervention |
Tic Disorder |
Behavioral: Habit Reversal Training Behavioral: Minimal Contact Waitlist |
Genetics Home Reference related topics: | familial paroxysmal nonkinesigenic dyskinesia Tourette syndrome |
Study Type: | Interventional |
Study Design: | Basic Science, Randomized, Single Blind (Outcomes Assessor), Parallel Assignment |
Official Title: | TRECC: Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders |
Estimated Enrollment: | 50 |
Study Start Date: | August 2007 |
Estimated Study Completion Date: | June 2010 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1: Active Comparator
Habit Reversal Training
|
Behavioral: Habit Reversal Training
Behavioral treatment consisting of:
|
2: Placebo Comparator
Minimal Contact Waitlist
|
Behavioral: Minimal Contact Waitlist
Biweekly phone contact to monitor child's clinical status.
|
Ages Eligible for Study: | 9 Years to 14 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Joni Zuckerbrow-Miller | 310-295-7667 | jzuckerbrow@mednet.ucla.edu |
Contact: Lu Lu | 310-825-0122 | lulu@mednet.ucla.edu |
United States, California | |||||
University of California, Los Angeles | Recruiting | ||||
Los Angeles, California, United States, 90024 | |||||
Contact: Fiona Whelan, M.S. 310-825-7874 fwhelan@mednet.ucla.edu | |||||
Principal Investigator: James McCracken, M.D. | |||||
Sub-Investigator: John Piacentini, Ph.D. | |||||
Sub-Investigator: Russell Poldrack, Ph.D. |
University of California, Los Angeles |
Study Director: | John Piacentini, Ph.D. | University of California, Los Angeles |
Principal Investigator: | James McCracken, M.D. | University of California, Los Angeles |
UCLA Child OCD, Anxiety, and Tic Disorders Program 
  |
Responsible Party: | UCLA ( John Piacentini, Ph.D. ) |
Study ID Numbers: | UCLAP500772484, P50 MH077248 |
First Received: | May 7, 2008 |
Last Updated: | May 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00675675 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|
|